The FDA is seeking feedback on a list of patient preference areas that it put together to help them take into account patients’ views as they make regulatory decisions about medical devices. Included on this list of patient preference areas is “Ear, Nose, and Throat: Treatments for moderate to severe hearing loss (implanted hearing devices vs. other treatment options).”
The FDA is seeking information or qualitative or quantitative assessments of whether patients prefer certain alternatives, outcomes or choices over others in terms of their health.
The FDA wants to understand how patients view the risks and benefits of a technology or treatment differently from how the risks and benefits are viewed by health-care professionals and caregivers and whether differences in patient perspectives are not well understood due to a variety of factors.
Check out their request for comments on the Federal Register.
Recent Posts
OMB Proposes Major Changes to Federal Grant Management Rules
The Office of Management and Budget’s (OMB) proposed revisions to the Uniform Guidance (2 CFR Part 200)—the government-wide rules governing federal grants and cooperative agreements—represent…
House FY 2027 LHHS Appropriations Bill Maintains Funding for Hearing Health Priorities, Eliminates PCORI Funding
The House Appropriations Committee has approved its Fiscal Year (FY) 2027 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill, which provides…
Newborn Hearing Screenings Made Easier: Why Did We Never Think of This?
In the United States, approximately 97 percent of babies born receive a newborn hearing screening (NBHS) (Centers for Disease Control and Prevention, 2022). There is…


